Gene · 4598
Papers1,777
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,777
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Medulloblastoma response to mevalonate pathway inhibition is independent of p53 status. | Biol Direct | 2026 | 41923098 | PubTator, text mining | PubMed |
| Case Report: Early-onset mevalonic aciduria in neonates with inflammatory marker elevated. | Front Immunol | 2026 | 41869348 | PubTator, text mining | PubMed |
| Systematic identification of variant-specific RNA structure-small molecule interactions exemplified by RNA G-quadruplexes. | Nat Commun | 2026 | 41857008 | PubTator, text mining | PubMed |
| Phenotype-genotype correlation and treatment outcomes in mevalonate kinase deficiency: A large Turkish cohort. | Semin Arthritis Rheum | 2026 | 41833237 | PubTator, text mining | PubMed |
| Pyrin inflammasome activation triggers an IL-18-driven IFN-γ response in mevalonate kinase deficiency. | J Allergy Clin Immunol | 2026 | 41812801 | PubTator, text mining | PubMed |
| Multi-omic profiling defines three distinct molecular subtypes of urothelial carcinoma with implications for precision therapy. | Clin Transl Med | 2026 | 41804750 | PubTator, text mining | PubMed |
| A 12-year expanding pink plaque on the chest. | JAAD Case Rep | 2026 | 41798138 | PubTator, text mining | PubMed |
| Clinical utility and genomic insights from whole exome and clinical exome sequencing in idiopathic liver disease. | Hum Mol Genet | 2026 | 41790749 | PubTator, text mining | PubMed |
| Clinical, immunological characterisation and treatment response of patients with syndrome of undifferentiated recurrent fever in Chinese children and adolescents: a single-centre cohort study. | Front Immunol | 2026 | 41789090 | PubTator, text mining | PubMed |
| Regulatory roles of bioactive lipids in vascular homeostasis and remodeling. | Med Rev (2021) | 2026 | 41783891 | PubTator, text mining | PubMed |
| Cytokine profiles and laboratory parameters as indicators to distinguish children with PFAPA and bacterial infection. | Front Immunol | 2026 | 41766872 | PubTator, text mining | PubMed |
| Identification of two novel MVD mutations and one novel FDPS mutation in Chinese patients with porokeratosis. | Front Med (Lausanne) | 2026 | 41737384 | PubTator, text mining | PubMed |
| STAT1 signaling controls cholesterol metabolism in epithelial cells and RSV-induced syncytia formation. | Npj Viruses | 2026 | 41699197 | PubTator, text mining | PubMed |
| Generation and characterization of iPSC-derived microglia for in vitro modeling of stimuli-specific neuroimmune responses. | Alzheimers Dement | 2026 | 41639038 | PubTator, text mining | PubMed |
| A Diagnostic Challenge: Recurrent Uveitis Leading to the Diagnosis of Hyper-IgD Syndrome in a 28-Year-Old Patient. | Ocul Immunol Inflamm | 2026 | 41635243 | PubTator, text mining | PubMed |
| Behçet's Disease: A Comprehensive Overview of Symptoms, Pathology, Genetics, and Treatment. | J Mother Child | 2026 | 41620945 | PubTator, text mining | PubMed |
| NAT10 drives hepatocellular carcinoma progression through SQLE-mediated cholesterol biosynthesis and is targetable by remodelin. | iScience | 2026 | 41550764 | PubTator, text mining | PubMed |
| Germline and somatic second-hit changes in porokeratosis: comprehensive variant spectrum and genotype-phenotype correlation analysis. | Br J Dermatol | 2026 | 41240373 | PubTator, text mining | PubMed |
| Rare Coexistence of Hidradenitis Suppurativa and Hyper-IgD Syndrome With Homozygous MVK V377I and Compound Heterozygous MEFV (M680I/E148Q) Mutations. | Pediatr Dermatol | 2026 | 41047723 | PubTator, text mining | PubMed |
| Integrated Bioinformatics Analysis Revealing that the NSDHL Gene Might Be Associated with the Progression of Western HFD/SW-Induced Hepatocellular Carcinoma | Endocr Metab Immune Disord Drug Targets | 2026 | 40033501 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4598/papers?page=2